Back to search
FDAFDA · Food and drugs·Recall number D-0812-2016

SODIUM IODIDE I 131 CAPSULE, USP DIAGNOSTIC ORAL , Rx only, Manufactured by Jubilant DraxImage, Inc., Kirkland, QC, Canada, NDC 65174-461-05

Published April 13, 2016 · Recall initiated: March 11, 2016

Summary

FDA records drug Class III recall D-0812-2016, published April 13, 2016 and initiated March 11, 2016. Recalling firm: Jubilant Draximage Inc; Status: Terminated; Reported quantity: 90 vials (450 capsules); Lot: Lot Number 1670123; Exp 04/16. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label Error on Declared Strength

What to do

Voluntary: Firm initiated · E-Mail

Get an email if SODIUM IODIDE I 131 DIAGNOSTIC has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
SODIUM IODIDE I 131 DIAGNOSTIC
Manufacturer
Jubilant Draximage Inc
Distributor
Nationwide
Lot
Lot Number 1670123; Exp 04/16
Risk classification
Class III
Area (FDA)
drug
Country
Canada

Related recalls

Questions about this recall

Was SODIUM IODIDE I 131 CAPSULE, USP DIAGNOSTIC ORAL , Rx only, Manufactured by Jubilant DraxImage, Inc., Kirkland, QC, Canada, NDC 65174-461-05 recalled?

Yes. FDA published recall D-0812-2016 on April 13, 2016. Reported hazard: Labeling: Label Error on Declared Strength

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: SODIUM IODIDE I 131 DIAGNOSTIC.